Exchange: NYSE·Updated 04:37 PM EDT
A logo

AAgilent Technologies Inc.

$134.29
$0.70
(0.52%)
Today
Closed $134.29
$0.00
(0.00%)
After Hours
EarningsAug 26
Mkt Cap$37.73B
Vol2.18M
News
all
press releases
Agilent Technologies Breaks Above 200-Day Moving Average - Bullish for A
In trading on Thursday, shares of Agilent Technologies, Inc. (Symbol: A) crossed above their 200 day moving average of $130.73, changing hands as high as $132.82 per share. Agilent Technologies, Inc. shares are currently trading up about 2.4% on the day. The chart below shows...
Nasdaq News: Markets
News Placeholder
More News
News Placeholder
Agilent Strengthens Biopharma Growth Prospects With AI Expansion
A enhances AI-powered lab software, automation and digital workflows to support drug discovery, biopharma research and long-term growth.
Zacks
News Placeholder
Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis
Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns, designed to support critical analytical workflows in biopharmaceutical development and...
Business Wire
News Placeholder
Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight
Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing manual cell segmentation steps and parameter tuning and supporting more consistent results. The software...
Business Wire
News Placeholder
Why Is Agilent (A) Up 0.1% Since Last Earnings Report?
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler
Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler...
Yahoo! Finance: News
News Placeholder
Agilent Completes Acquisition of Biocare Medical
Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction...
Business Wire
News Placeholder
Is the Options Market Predicting a Spike in Agilent Technologies Stock?
Investors need to pay close attention to A stock based on the movements in the options market lately.
Zacks
News Placeholder
Strength in Technology Enabled Products Drives Roper: Can the Momentum Sustain?
ROP's Technology Enabled Products segment is benefiting from medical product demand, helping support its 2026 growth outlook.
Zacks
News Placeholder
Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation
Agilent Technologies Inc. (NYSE: A) today announced a collaboration with OpenAI and Boston Consulting Group (BCG) to accelerate the deployment of artificial intelligence (AI) across the companys products, operations, and customer workflows. AI is a top priority, and this partnership reflects both...
Business Wire
<
1
2
...
>

Advertisement|Remove ads.